Sunil Healthcare — 360° view

Sunil Healthcare, a company in the Pharmaceuticals industry, reported revenue of ₹19 crore and net profit of ₹0.24 crore for the September 2026 quarter.

Sunil Healthcare (NSE: SUNLOC) closed at ₹70.00 on 19 Nov 2026. Its market capitalisation is ₹72 crore and it trades at 24.5 times earnings.

Share price
₹70.00 (19 Nov 2026)
Market cap
₹72 Cr (19 Nov 2026)
P/E
24.50 (19 Nov 2026)
Revenue
₹19 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
6.43% (FY26)
ROE
6.01% (FY26)
Book value
₹71.0 (FY26)
Dividend yield
0.00% (last 12 months to 19 Nov 2026)
52-week high / low
₹82.00 / ₹60.00 (19 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: SUNLOC

Incorporated in 1976, Sunil Healthcare Ltd is a certified manufacturer of Empty Hard Gelatin capsules shell and HPMC Capsules shell.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.